Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) | PAR 25 256

Opportunity Information: Apply for PAR 25 256

The National Institutes of Health (NIH) is offering a discretionary grant opportunity titled "Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)" under Funding Opportunity Number PAR-25-256. This opportunity uses the NIH R21 mechanism, which is designed to support early-stage, high-impact, and often higher-risk projects that focus on developing new concepts, theories, analytic frameworks, or methods rather than completing large, definitive studies. As stated in the title, clinical trials are not allowed under this notice of funding opportunity (NOFO), so proposed work should center on theory and methods development and on validating those methods using existing resources rather than testing interventions in a trial setting.

The central goal of the NOFO is to fund novel theory and methodological advances that clarify how both genetic and non-genetic factors shape variation in complex human traits. In practical terms, NIH is looking for approaches that move beyond simple "genes vs. environment" framing and instead offer better ways to model, quantify, and interpret the many contributors to trait differences across individuals, families, and populations. The NOFO emphasizes that complex traits are influenced by multiple interacting forces, including biological processes, social environments, and broader ecological contexts, and it encourages applicants to build methods that can handle those interdependencies and layered influences in a coherent way.

A key theme is interdisciplinarity across the natural and social sciences. Competitive applications will likely integrate ideas from fields such as statistical genetics, genomics, epidemiology, biostatistics, demography, sociology, anthropology, psychology, economics, ecology, and computational modeling. The NOFO specifically calls for approaches that account for connections across scales of organization, meaning methods should be able to represent how processes at one level (for example, molecular or cellular biology) relate to higher-level patterns (like family structure, neighborhood conditions, social networks, or population history), and how these levels can feed back on each other. This could include theoretical work on gene-environment interplay, methods that incorporate social and structural determinants of health into genetic models, or frameworks that improve causal inference when genetic and environmental exposures are correlated.

NIH also signals a strong preference for rigorous methodological development supported by extensive use of theory, simulations, and validation with available large-scale datasets. That means applicants are expected to (1) clearly motivate the new method or theoretical framework, (2) stress-test it through simulation studies that explore realistic data challenges (such as confounding, measurement error, ancestry-related structure, relatedness, selection bias, or missingness), and (3) demonstrate performance in real-world settings by applying the method to existing large datasets, rather than proposing to generate entirely new cohorts for primary data collection. Validation using established biobanks, longitudinal studies, family-based datasets, or other widely used resources would fit well with this emphasis, as long as the work remains focused on methods and theory rather than a purely descriptive analysis of one trait.

In terms of eligibility, the opportunity is broadly open. Eligible applicants include many types of U.S. governmental entities (state, county, city/township, special districts), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized Native American tribal governments, and tribal organizations that are not federally recognized. It is also open to public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education); for-profit organizations (other than small businesses) and small businesses; and additional categories listed as "others." The NOFO explicitly highlights additional eligible applicant types as well, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations). This wide eligibility is consistent with the interdisciplinary nature of the work and the desire to draw in expertise from many sectors and research environments.

From an administrative standpoint, the awarding agency is NIH and the funding instrument is a grant. The activity areas align with education and health, and the CFDA numbers associated with the opportunity are 93.172 and 93.399. The opportunity was created on November 15, 2024, and the original closing date listed is January 7, 2027. The notice does not provide an award ceiling or expected number of awards in the provided text, so applicants would typically look to the full NOFO for any institute- or program-specific budget guidance and for details about typical R21 budget limits, project periods, and review criteria.

Overall, this NOFO is aimed at researchers who want to build the next generation of conceptual and analytical tools for understanding complex human traits in a way that is scientifically rigorous and socially informed. The strongest proposals will usually be those that offer a clearly novel method or theoretical advance, demonstrate why existing approaches fall short, show through simulations that the new approach behaves well under realistic conditions, and provide credible validation using large-scale datasets while respecting the "clinical trial not allowed" boundary.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172, 93.399.
• This funding opportunity was created on 2024-11-15.
• Applicants must submit their applications by 2027-01-07.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 25 256

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: